Evidence map›Paper›PMID 32926329›Full record

ArticleNeuromolecular medicine2021

Docosahexaenoic Acid (DHA) Supplementation Alters Phospholipid Species and Lipid Peroxidation Products in Adult Mouse Brain, Heart, and Plasma.

Grace Y Sun, Michael K Appenteng, Runting Li, Taeseon Woo, Bo Yang, Chao Qin, Meixia Pan, Magdalena Cieślik, Jiankun Cui, Kevin L Fritsche and 6 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Neuromolecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Grace Y SunDepartment of Biochemistry, University of Missouri, Columbia, MO, 65211, USA.
Michael K AppentengDepartment of Chemistry, University of Missouri, 125 Chemistry Bldg., Columbia, MO, 65211, USA.
Runting LiDepartment of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO, 65211, USA.
Taeseon WooInterdisciplinary Neuroscience Program, University of Missouri, Columbia, MO, 65211, USA.
Bo YangDepartment of Chemistry, University of Missouri, 125 Chemistry Bldg., Columbia, MO, 65211, USA.
Chao QinBarshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA.
Meixia PanBarshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA.
Magdalena CieślikDepartment of Cellular Signaling, Mossakowski Medical Research Centre, Polish Academy of Sciences, 02-106, Warsaw, Poland.
Jiankun CuiDepartment of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO, 65211, USA.
Kevin L FritscheDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO, 65211, USA.
Zezong GuDepartment of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO, 65211, USA.
Matthew WillDepartment of Psychological Sciences, University of Missouri, Columbia, MO, 65211, USA.
David BeversdorfInterdisciplinary Neuroscience Program, University of Missouri, Columbia, MO, 65211, USA.
Agata AdamczykDepartment of Cellular Signaling, Mossakowski Medical Research Centre, Polish Academy of Sciences, 02-106, Warsaw, Poland.
Xianlin HanBarshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA.
C Michael GreenliefDepartment of Chemistry, University of Missouri, 125 Chemistry Bldg., Columbia, MO, 65211, USA. greenliefm@missouri.edu.ORCID 0000-0001-6420-7375
University of Missouri · USThe University of Texas Health Science Center at San Antonio · USMossakowski Medical Research Institute, Polish Academy of Sciences · PL

Funding

TRANSGENIC COREP30AG013319 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JAMES FLOYD NELSON · 1995 to 2026
$30.6M
South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Mohamad Habes · 2021 to 2026
$24.0M
Identification of a missing key element underlying apoE2 neuroprotection in Alzheimer's disease and the aging brainRF1AG061872 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HAN, XIANLIN, SESHADRI, SUDHA · 2018 to 2018
$3.4M
NIA NIH HHS P30 AG013319NIA NIH HHS P30 AG066546NIA NIH HHS RF1 AG061872
6 · The paper itself

Abstract

The abundance of docosahexaenoic acid (DHA) in phospholipids in the brain and retina has generated interest to search for its role in mediating neurological functions. Besides the source of many oxylipins with pro-resolving properties, DHA also undergoes peroxidation, producing 4-hydroxyhexenal (4-HHE), although its function remains elusive. Despite wide dietary consumption, whether supplementation of DHA may alter the peroxidation products and their relationship to phospholipid species in brain and other body organs have not been explored sufficiently. In this study, adult mice were administered a control or DHA-enriched diet for 3 weeks, and phospholipid species and peroxidation products were examined in brain, heart, and plasma. Results demonstrated that this dietary regimen increased (n-3) and decreased (n-6) species to different extent in all major phospholipid classes (PC, dPE, PE-pl, PI and PS) examined. Besides changes in phospholipid species, DHA-enriched diet also showed substantial increases in 4-HHE in brain, heart, and plasma. Among different brain regions, the hippocampus responded to the DHA-enriched diet showing significant increase in 4-HHE. Considering the pro- and anti-inflammatory pathways mediated by the (n-6) and (n-3) polyunsaturated fatty acids, unveiling the ability for DHA-enriched diet to alter phospholipid species and lipid peroxidation products in the brain and in different body organs may be an important step forward towards understanding the mechanism(s) for this (n-3) fatty acid on health and diseases.

Indexed as

Dietary SupplementsAldehydesAnimalsBrainChromatography, LiquidDocosahexaenoic AcidsHeartLipid PeroxidationMaleMiceMice, Inbred C57BLMyocardiumOrgan SpecificityOxidation-ReductionPhospholipidsPlasma4-hydroxyhexenalAldehydesDocosahexaenoic AcidsPhospholipidsDocosahexaenoic acidHeartHippocampusLipidomicsLipid peroxidationPlasma

Identifiers

PMID32926329
PMCPMC9555299
OpenAlexW3086769128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.